Dapsone Gel 5%
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $41,910 | 1 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $41,910 | 1 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Study to Evaluate the Relative Bioavailability of a Test Formulation of Dapsone Gel, 5% (Amneal Pharmaceuticals) Compared to ACZONE (dapsone) Gel, 5% (Allergan, Inc.) in Healthy Adult Male Subjects (11649701) | Amneal Pharmaceuticals LLC | $41,910 | 0 |
Top Doctors Receiving Payments for Dapsone Gel 5%
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Pittsburgh, PA | $41,910 | 1 |
Manufacturing Companies
- Amneal Pharmaceuticals LLC $41,910
Product Information
- Type Drug
- Total Payments $41,910
- Total Doctors 0
- Transactions 1
About Dapsone Gel 5%
Dapsone Gel 5% is a drug associated with $41,910 in payments to 0 healthcare providers, recorded across 1 transactions in the CMS Open Payments database. The primary manufacturer is Amneal Pharmaceuticals LLC.
Payment data is available from 2017 to 2017. In 2017, $41,910 was paid across 1 transactions to 0 doctors.
The most common payment nature for Dapsone Gel 5% is "Unspecified" ($41,910, 100.0% of total).
Dapsone Gel 5% is associated with 1 research study, including "A Study to Evaluate the Relative Bioavailability of a Test Formulation of Dapsone Gel, 5% (Amneal Pharmaceuticals) Compared to ACZONE (dapsone) Gel, 5% (Allergan, Inc.) in Healthy Adult Male Subjects (11649701)" ($41,910).